The Discounted Cash Flow (DCF) valuation of Resmed Inc (RMD) is 293.30 USD. With the latest stock price at 220.47 USD, the upside of Resmed Inc based on DCF is 33.0%.
Based on the latest price of 220.47 USD and our DCF valuation, Resmed Inc (RMD) is a buy. buying Resmed stocks now will result in a potential gain of 33.0%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.9% | 8.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 200.83 - 584.23 | 293.30 |
| Upside | -8.9% - 165.0% | 33.0% |